{
  "docId": "019de073-bb7b-734e-9815-c76c1fc3394d",
  "docSlug": "94fe5c987d3cc2789a772bd63dd63a40",
  "documentTitle": "Genprex | Investor Presentation Deck | 39 slides",
  "authorId": "genprex",
  "authorName": "Genprex",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 39,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide outlines the clinical trial methodology for a drug combination study.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bb7b-734e-9815-c76c1fc3394d/17",
  "deckHref": "/decks/019de073-bb7b-734e-9815-c76c1fc3394d",
  "deckJsonHref": "/decks/019de073-bb7b-734e-9815-c76c1fc3394d.json",
  "deckAnchorHref": "/decks/019de073-bb7b-734e-9815-c76c1fc3394d#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.385,
        "w": 0.95,
        "x": 0.025,
        "y": 0.542
      },
      "kind": "list",
      "text": "PHASE 2 COMPONENT: Randomized 1:1, open-label, 2-arm study of REQORSA in combination with Tagrisso vs. Tagrisso monotherapy; Primary Endpoint: PFS; Secondary Endpoints: Overall response rate, Overall survival, Tolerability, Number of adverse events",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87778626-3aac-43cb-8ed6-7e3ac09a62d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.285,
        "w": 0.95,
        "x": 0.025,
        "y": 0.198
      },
      "kind": "list",
      "text": "PHASE 1 COMPONENT: 3+3 dose escalation of REQORSA in combination with Tagrisso; Primary Endpoint: Dose limiting toxicity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d5a0d4fd-b8aa-4ffc-b520-6a9c2b5b1fa6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.304,
        "x": 0.348,
        "y": 0.045
      },
      "kind": "title",
      "text": "Acclaim-1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f758fee-433a-412b-b517-fb17b3538a95",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "9e84e9b9-ac96-45db-883f-9c456850c359",
      "evidence": "Structured breakdown of study phases, designs, and endpoints.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 13,
      "beatId": "efbd2b1c-a70c-482c-b892-45fe876c5387",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "REQORSA MONOTHERAPY, REQORSA + TARCEVA COMBINATION, etc.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}